10,936
Total Claims
$915K
Drug Cost
1,530
Beneficiaries
$598
Cost/Patient
Peer Comparison vs. 218,535 Nurse Practitioner providers
-49%
Cost per patient vs peers
$598 vs $1,174 avg
+3%
Brand preference vs peers
9.1% vs 8.9% avg
Brand vs Generic
91% generic
Brand: 999 claims · $712K
Generic: 9,937 claims · $203K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 303 | $243K |
| Rivaroxaban | 149 | $126K |
| Sacubitril/Valsartan | 130 | $126K |
| Evolocumab | 107 | $82K |
| Ticagrelor | 82 | $57K |
| Dapagliflozin Propanediol | 52 | $39K |
| Ranolazine | 171 | $26K |
| Metoprolol Succinate | 1,370 | $21K |
| Rosuvastatin Calcium | 906 | $19K |
| Alirocumab | 21 | $17K |
| Empagliflozin | 14 | $16K |
| Ezetimibe | 384 | $14K |
| Isosorbide Mononitrate | 622 | $11K |
| Clopidogrel Bisulfate | 606 | $8,892 |
| Carvedilol | 900 | $8,852 |
Prescribing Profile
59
Unique Drugs
$549K
Patient Profile
72
Avg Age
53%
Female
1.75
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data